Compare
Family Office of America, Inc. vs Catheter Precision, Inc. vs EBR Systems, Inc. vs INVO Fertility, Inc.
| Latest fiscal year | Family Office of America, Inc. FOFA | Catheter Precision, Inc. VTAK | EBR Systems, Inc. NONE. | INVO Fertility, Inc. IVF |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $221.8K | $819.0K | $1.62M | $6.84M |
| Revenue growth (YoY) | n/a | +95.0% | n/a | +4.7% |
| Gross margin | 100.0% | 92.3% | 30.3% | n/a |
| Operating margin | -226.0% | n/m | n/m | -105.8% |
| Net margin | -222.2% | n/m | n/m | -340.9% |
| Net income | -$492.7K | -$17.18M | -$48.76M | -$23.32M |
| EPS (Diluted) | -$0.02 | n/a | -$0.12 | -$214.64 |
| Operating cash flow | -$262.2K | -$8.30M | -$53.19M | -$7.01M |
| Free cash flow | n/a | -$8.31M | -$56.88M | -$7.06M |
| Cash & equivalents | n/a | $88.0K | $5.79M | n/a |
| Total assets | $1.54M | $15.86M | $97.23M | $20.22M |
| Total liabilities | $878.5K | $9.21M | $71.64M | $13.00M |
| Shareholders' equity | $664.5K | $7.05M | $25.59M | $7.22M |
| Return on year-end equity | -74.2% | -243.6% | -190.6% | -322.8% |
| Shares outstanding | 30.20M | 1.74M | 450.26M | 477.4K |
Revenue, most recent five fiscal years
| Fiscal year | Family Office of America, Inc. | Catheter Precision, Inc. | EBR Systems, Inc. | INVO Fertility, Inc. |
|---|---|---|---|---|
| Latest | $221.8K Ended 2025-12-31 | $819.0K Ended 2025-12-31 | $1.62M Ended 2025-12-31 | $6.84M Ended 2025-12-31 |
| 1 year earlier | n/a | $420.0K Ended 2024-12-31 | n/a | $6.53M Ended 2024-12-31 |
| 2 years earlier | n/a | $442.0K Ended 2023-12-31 | n/a | $3.02M Ended 2023-12-31 |
| 3 years earlier | n/a | $14.0K Ended 2022-12-31 | n/a | n/a |
| 4 years earlier | n/a | $22.0K Ended 2021-12-31 | n/a | n/a |